ISSN:

Journal Home

Journal Guideline

Molecular Cancer Therapeutics Q1 Unclaimed

American Association for Cancer Research Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Molecular Cancer Therapeutics is a journal indexed in SJR in Oncology and Cancer Research with an H index of 173. It has a price of 3000 €. It has an SJR impact factor of 2,717 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,717.

Molecular Cancer Therapeutics focuses its scope in these topics and keywords: inhibitor, cancer, potent, cells, protein, resistance, activity, receptor, inhibition, vitro, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Oncology (Q1)

Price

3000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

2,717

SJR Impact factor

173

H Index

244

Total Docs (Last Year)

747

Total Docs (3 years)

10829

Total Refs

4623

Total Cites (3 years)

726

Citable Docs (3 years)

5,27

Cites/Doc (2 years)

44,38

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

JAMA oncology Q1
Annals of Oncology Q1
Molecular Cancer Q1
CA - A Cancer Journal for Clinicians Q1
Cancer Discovery Q1

Compare this journals